Brief: CytRx to complete enrollment in Aldoxorubicin trial in 2015

LadRx

20/10/2014 10:59

Oct 20 (Reuters) - CytRx Corp  CYTR.O : 
 * Press release - CytRx announces publication of phase 1b/2 aldoxorubicin 
   clinical data in soft tissue sarcoma in cancer, the peer-reviewed journal of 
   the American cancer society 
 * Says aldoxorubicin was generally well tolerated, with no clinically 
   significant cardiotoxicities and no drug-related deaths 
 * On track to complete enrollment in ongoing global phase 3 clinical trial of 
   aldoxorubicin in the second half of 2015 
 
* Source text for Eikon  ID:nPn8GfRBD  
 
* Further company coverage  CYTR.O  
 
 ((Bangalore Newsroom; +1 646 223 8780))